ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation
Frank T. Kolligs, Marvin T. Nieman, Ira Winer, Gang Hu, David Van Mater, Ying Feng, Ian M. Smith, Rong Wu, Yali Zhai, Kathleen R. Cho, Eric R. FearonVolume:
1
Year:
2002
Language:
english
DOI:
10.1016/s1535-6108(02)00035-1
File:
PDF, 552 KB
english, 2002